Home/Opko Health/Phillip Frost, M.D.
PF

Phillip Frost, M.D.

Chairman and Chief Executive Officer

Opko Health

Roles

Chairman and Chief Executive OfficeratOpko Health

Opko Health Pipeline

DrugIndicationPhase
NGENLA™ (somatrogon)Pediatric Growth Hormone DeficiencyMarket
RAYALDEE® (calcifediol)Secondary Hyperparathyroidism in CKDMarket
MDX2004Advanced CancersPhase 1
Multispecific Antibodies (with Regeneron)Select Therapeutic IndicationsResearch
Oral Long-Acting PTH TabletHypoparathyroidismPreclinical
Nanoparticle VaccinesInfectious DiseasesResearch